Dergiler / Eastern Journal of Medicine / 2017 / Cilt: 22 - Sayı: 4

The role of paroxysmal nocturnal hemoglobinuria in idiopathic habitual abortion

Sayfa
143–146
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

PNH clone positivity results in the study group indicate that PNH should be investigated in cases of idiopathic HA, as one patient required treatment.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Paroxysmal nocturnal hemoglobinuria (PNH) which is an acquired clonal hematopoietic stem cell disease, usually presents with intravascular hemolysis, thrombosis and bone marrow failure.
📊
Temel Bulgular & Veri:Hereditary and acquired thrombophilia are known to play significant role in the etiology of patients with habitual abortion (HA).
💡
Sonuç & Katkı:PNH clone positivity results in the study group indicate that PNH should be investigated in cases of idiopathic HA, as one patient required treatment.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Abstract

Paroxysmal nocturnal hemoglobinuria (PNH) which is an acquired clonal hematopoietic stem cell disease, usually presents with intravascular hemolysis, thrombosis and bone marrow failure. Hereditary and acquired thrombophilia are known to play significant role in the etiology of patients with habitual abortion (HA). PNH, which is a cause of acquired thrombophilia, may have a role in the etiology of HA. In the present study, we investigated the presence of PNH clone among the patients with a history of HA. 150 patients were enrolled in the study group, diagnosed with habitual abortus of unknown etiology and 150 healthy women with no history of habitual abortus as a control group. The age range for both groups was 18-55 years. The PNH clone was screened by the FLAER (fluorescein-labeled proaerolysin) method. The PNH clone was positive in five (3.3%) patients in the study group. Four of the PNH clone positive patie nts were found to have a very low clone positivity level (0.05%, 0.24%, 0.12%, 0.21%), while one had a high level (30%). PNH clone positivity results in the study group indicate that PNH should be investigated in cases of idiopathic HA, as one patient required treatment.

🔖

Bu Makaleye Atıf Yap

DİRİK, Y., EKİNCİ, Ö., KARA, O., DİRİK, D., DOĞAN, A., DEMİR, C. (2017). The role of paroxysmal nocturnal hemoglobinuria in idiopathic habitual abortion. Eastern Journal of Medicine, Cilt: 22 - Sayı: 4, 143–146. https://ajindex.com/articles/222598

Kaynakça (16)

  1. Parker CJ. Paroxysmal Nocturnal Hemoglobinuria. In: Williams Hematology. 8th ed. Kaushansky K, ed. California, CA: McGrawHill; 2010: 521-531
  2. Hillmen P, Lewis SM, Bessler M, Luzzatto L, Dacie JV. Natural history of paroxysmal nocturnal hemoglobinuria. N Engl J Med 1995; 333: 1253-1258
  3. American College of Obstetricians and Gynecologists. Management of recurrent early pregnancy loss. ACOG Practice Bulletin 2001; 24: 1-8
  4. Tabassum Parveiz MD. Recurrent Pregnancy Loss. JK-Practitioner 2003; 10: 323-326
  5. Preston FE, Rosendaal FR, Walker ID, et al. Increased fetal loss in women with heritable thrombophilia. Lancet 1996; 348: 913-916
  6. Rey E, Kahn SR, David M, Shrier I. Thrombophilic disorders and fetal loss: a metaanalysis. Lancet 2003; 361: 901-908
  7. Stevenson JL, Choi SH, Varki A. Differential metastasis inhibition by clinically relevant levels of heparins-correlation with selectin inhibition, not antithrombotic activity. Clin Cancer Res 2005; 11: 7003-7011
  8. Sood R. Thrombophilia and fetal loss: Lessons from gene targeting in mice. Thromb Res 2009; 123 Suppl 2: 79-84
  9. Kutteh WH, Park VM, Deitcher SR. Hypercoagulable state mutation analysis in white patients with early first- trimester recurrent pregnancy loss. Fertil Steril 1998; 71: 1048-1053
  10. Goodman CS, Coulam CB, Jeyendran RS, Vida AA, Roussev R. Which thrombophilic gene mutations are risk factors for recurrent pregnancy loss? Am J Rep Imnunol 2006; 56: 230-236
  11. Bick RL, Hoppensteadt D. Recurrent miscarriage syndrome and infertility due to blood coagulation protein/platelet defects: A review and update. Clin App Thromb Hemost 2005; 11: 1-13
  12. Dilley A, Benito C, Hooper WC, et al. Mutations in the factor V, prothrombin and MTHFR genes are not risk factors for recurrent fetal loss. J Matern Fetal Neonatal Med 2002; 11: 176-182
  13. Foka ZJ, Lambropoulos AF, Saravelos H, et al. Factor V Leiden and prothrombin G20210A mutations, but not methylenetetrahydrofolate reductase C677T, are associated with recurrent miscarriages. Hum Reprod 2000; 15: 458-462
  14. Rai RS, Regan L, Clifford K. Antiphospholipid antibodies and ß-2 glycoprotein-I in 500 women with recurrent miscarriage: results of a comprehensive screening approach. Hum. Reprod 1995; 10: 2001-2005
  15. Nishimura J, Kanakura Y, Ware RE, et al. Clinical course and flow cytometric analysis of paroxysmal nocturnal hemoglobinuria in the United States and Japan. Medicine (Baltimore). Medicine 2004; 83: 193-207
  16. Moyo VM, M